Date
16 September 2026Location
Online, via Webex, 13.00-14.00pmAbout the event
Speakers from NHS England and NHS SPS shared insights to help organisations plan for, and implement, biosimilar and key generic medicines.
The update included practical advice on engaging patients about biosimilars, and attendees submitted questions in advance via this Microsoft Forms short survey.
The webinar was intended for NHS procurement and clinical teams implementing biosimilar and high value generic medicines. It was not recorded as some information is commercially confidential and subject to change.
Why it’s important
Implementation of biosimilar and key generic medicines requires collaborative working across the system. The use of biological medicines, including biosimilars, is expanding in clinical practice.
Timely implementation and use of biosimilar and key generic medicines offers the NHS opportunities to deliver better value for certain conditions.
What was covered
- Information to support system planning and mobilisation for aripiprazole, ferric carboxymaltose, and HIV medicines
- Engaging patients with biosimilar medicines and switching
- A question and answer session
Speakers
A range of speakers from SPS and other organisations helped run this event.
Non-SPS speakers
Anna Kafkalia
Senior Programme of Care Manager, Blood and Infection, NHS England National Specialised Commissioning
SPS speakers
Learn more about the SPS team facilitating this event.
Presentation slides
Some of the slides from the presentation are now available below.
Information presented in these resources was correct at time of recording. Current guidance should be followed.
Contact us
Please contact the admin team via our email address if you have any questions.
Update history
- Added resources
- Updated to past tense and removed registration.
- Published